# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-24-000009
Filing Date
2024-05-09
Accepted
2024-05-09 07:52:53
Documents
68
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | carm-20240331.htm iXBRL | 10-Q | 1293998
2 | EX-31.1 | carm-20240331xexx311.htm | EX-31.1 | 10674
3 | EX-31.2 | carm-20240331xexx312.htm | EX-31.2 | 10671
4 | EX-32.1 | carm-20240331xexx321.htm | EX-32.1 | 4985
5 | EX-32.2 | carm-20240331xexx322.htm | EX-32.2 | 4980
| Complete submission text file | 0001485003-24-000009.txt |  | 5446549

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | carm-20240331.xsd | EX-101.SCH | 45563
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | carm-20240331_cal.xml | EX-101.CAL | 59585
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | carm-20240331_def.xml | EX-101.DEF | 122882
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | carm-20240331_lab.xml | EX-101.LAB | 574497
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | carm-20240331_pre.xml | EX-101.PRE | 362150
72 | EXTRACTED XBRL INSTANCE DOCUMENT | carm-20240331_htm.xml | XML | 466294

Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 24928651
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)